Leucine-Rich alpha-2 Glycoprotein 1 (LRG1) (N-Term) Peptide
Aperçu rapide pour Leucine-Rich alpha-2 Glycoprotein 1 (LRG1) (N-Term) Peptide (ABIN8104340)
Antigène
Origine
Source
Application
-
-
Protein Region
- N-Term
-
Fonction
- LRG1 Peptide - N-terminal region
-
Séquence
- GVTLSPKDCQ VFRSDHGSSI SCQPPAEIPG YLPADTVHLA VEFFNLTHLP
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti-LRG1 Antibody(ARP52475_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- LRG1 (Leucine-Rich alpha-2 Glycoprotein 1 (LRG1))
-
Sujet
-
Background Information: The leucine-rich repeat (LRR) family of proteins, including LRG1, have been shown to be involved in protein-protein interaction, signal transduction, and cell adhesion and development. LRG1 is expressed during granulocyte differentiation (O'Donnell et al., 2002 [PubMed 12223515]).
Alternative Symbols: HMFT1766, LRG
-
Poids moléculaire
- 38kDa
-
ID gène
- 116844
-
NCBI Accession
- NP_443204
-
UniProt
- P02750
Antigène
-